When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LIFE - Dosing in Phase 1 trial in aTyr Pharma's ATYR1923 conducted in Japan
aTyr Pharma Inc.
ATyr Pharma (NASDAQ:LIFE)announced that its partner Kyorin Pharmaceutical, a wholly owned subsidiary of Kyorin Holdings has dosed the first subjects in a Phase 1 trial of aTyr’s lead therapeutic candidate ATYR1923.
More news on: aTyr Pharma, Inc., Healthcare stocks news